Varlitinib Withdrawn Phase 2 Trials for Advanced or Metastatic Biliary Tract Cancer Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03129074Study of Varlitinib Plus Capecitabine in Patients With Advanced or Metastatic Biliary Tract Cancer